All In Biotech

Drug Trial Radar · NCT01872715

Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea

Last checked: Nov 20, 2026Latest source record: Aug 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

24

Actual

Start

Mar 2013

Primary completion

Jun 2013

Study completion Jun 2013

Sponsor

Lead sponsor
Galderma R&DIndustry
Sponsor type
Industry
First posted
Jun 7, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 25 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to characterize rosacea patients', being treated with Oracea, perception through visual analog scale reporting.

Conditions

  • Papulopustular Rosacea

Interventions

  • OraceaDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rosacea Score on the Visual Analog ScaleTime frame: Baseline, Weeks 2, 6, and 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stephens & Associates Dallas Research Center

    Carrollton, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.